InvestorsHub Logo

arizona1

08/04/18 7:54 PM

#285931 RE: nlightn #285891

That's spectacular! Thank you for the link. The entire pharma industry is a scam!

fuagf

08/05/18 4:40 AM

#285963 RE: nlightn #285891

nlightn, Was the EpiPen Hack Ethical?

"Meet the Anarchists Making Their Own Medicine"

There you go, there are anarchists who duck-and-weave to create things to help people (The Four Thieves Vinegar Collective gotta rank more as good guys than bad) and there are anarchists who condone destruction of property and violence in their desire to destroy. Lol, that is the best article i've seen to shove in the face of those who rant at all anarchists out there.

Of course questions popped in in reading it, questions all answered in this shorter article. Before that i'll just say it was good to see, at 3:30 here .. https://archive.org/details/EpiPencilUpdate (linked in yours), Michael Laufer, warn people off one homeopathic remedy, Des Bio, sold as Homeopathic Epinephrine, as not being a place to go. His comment was similar to an FDA warning i read way back warning people that homeopathic stuff is usually useless and can be dangerous.

It's a good little video too.
..


Michael Laufer holding his Epi-Pencil. (Four Thieves Vinegar Collective)

Update June 5, 2017

From The New York Times Sunday: Charles Duhigg writes that last year's outrage over Mylan ratcheting up the price of the EpiPen, so that patients out-of-pocket costs increased by over 500 percent in a few years, has not resulted in the company lowering the price of the product. Duhigg writes:

Mylan has been called out again and again over the years — by the company’s own employees, regulators, patients, politicians and the press — and hasn’t changed, even as revenue has skyrocketed, hitting $11 billion last year. The firm is a case study in the limits of what consumer and employee activism, as well as government oversight, can achieve.

Meanwhile last week, Iowa Republican Sen. Charles Grassley announced that the government has estimated Mylan may have overcharged Medicaid by as much as $1.27 billion for the EpiPen under the agency's drug rebate program.

Sponsored By

Original post from Jan. 23, 2017

Where questions of quality and safety and others were answered - https://www.kqed.org/futureofyou/323092/was-the-epipen-hack-ethical